Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) is set to release its earnings data after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of ($0.20) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link. Lexicon […]
Baystate Wealth Management LLC Invests $28,000 in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) VP Wendy Mcdermott bought 6,000 shares of the firm’s stock in a transaction dated Friday, August 4th. The shares were acquired at an average price of $1.84 per share, for a total transaction of $11,040.00. Following the completion of the transaction, the vice president now owns 28,478 […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) CEO Lonnel Coats acquired 10,000 shares of Lexicon Pharmaceuticals stock in a transaction that occurred on Thursday, June 29th. The shares were purchased at an average cost of $2.16 per share, with a total value of $21,600.00. Following the purchase, the chief executive officer now owns 814,359 shares […]
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Rating) had its target price upped by equities researchers at Citigroup from $6.00 to $8.00 in a note issued to investors on Wednesday, The Fly reports. Citigroup’s price objective would suggest a potential upside of 195.20% from the stock’s current price. A number of other brokerages also recently issued reports […]